77 related articles for article (PubMed ID: 23484536)
1. Trends in drug discovery technologies - meeting highlights from MipTec 2007.
Klumpp M; Mayr LM
Expert Opin Drug Discov; 2007 Oct; 2(10):1415-9. PubMed ID: 23484536
[TBL] [Abstract][Full Text] [Related]
2. Trends in drug discovery technologies - conference report from MipTec 2006.
Klumpp M; Mayr LM
Expert Opin Drug Discov; 2006 Sep; 1(4):361-4. PubMed ID: 23495906
[TBL] [Abstract][Full Text] [Related]
3. Report on the 10th anniversary of international drug discovery science and technology conference, 8 - 10 november 2012, nanjing, china.
Everett JR
Expert Opin Drug Discov; 2013 Mar; 8(3):357-61. PubMed ID: 23339328
[TBL] [Abstract][Full Text] [Related]
4. Introduction to the special issue on the joint meeting of the 19th IEEE International Symposium on the Applications of Ferroelectrics and the 10th European Conference on the Applications of Polar Dielectrics.
Tsurumi T
IEEE Trans Ultrason Ferroelectr Freq Control; 2011 Sep; 58(9):1712-3. PubMed ID: 21937301
[TBL] [Abstract][Full Text] [Related]
5. The 18th European symposium on quantitative structure-activity relationships.
Tsantili-Kakoulidou A; Agrafiotis DK
Expert Opin Drug Discov; 2011 Apr; 6(4):453-6. PubMed ID: 22646021
[TBL] [Abstract][Full Text] [Related]
6. 10th annual drug discovery technology(®) europe and infotechpharma(®) conference.
Kiyani S; Quigley E; Schlachter A; Treadway A
Expert Opin Drug Discov; 2006 Jun; 1(1):91-4. PubMed ID: 23506035
[TBL] [Abstract][Full Text] [Related]
7. Optimizing candidate selection--a vision in business limited conference. 1-2 December 1998, Basel, Switzerland.
Audus KL
IDrugs; 1999 Feb; 2(2):91-3. PubMed ID: 16160941
[TBL] [Abstract][Full Text] [Related]
8. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
Hafner J
J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
[TBL] [Abstract][Full Text] [Related]
9. Medicinal Chemistry--XVth EFMC International Symposium. New technologies in drug discovery. 6-10 September 1998, Edinburgh, Scotland, UK.
Buckle DR
IDrugs; 1998 Dec; 1(8):860-2. PubMed ID: 16196472
[TBL] [Abstract][Full Text] [Related]
10. Drug discovery in the era of Facebook--new tools for scientific networking.
Bailey DS; Zanders ED
Drug Discov Today; 2008 Oct; 13(19-20):863-8. PubMed ID: 18678275
[TBL] [Abstract][Full Text] [Related]
11. American Society of Clinical Oncology - 36th Annual Meeting.
Morse MA
IDrugs; 2000 Aug; 3(8):846-50. PubMed ID: 16059792
[TBL] [Abstract][Full Text] [Related]
12. Knowledge-based approaches in the design and selection of compound libraries for drug discovery.
Viswanadhan VN; Balan C; Hulme C; Cheetham JC; Sun Y
Curr Opin Drug Discov Devel; 2002 May; 5(3):400-6. PubMed ID: 12058615
[TBL] [Abstract][Full Text] [Related]
13. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
14. Selected highlights of the Third Annual Biomarkers Congress: from discovery to validation in the drug development arena.
Currid CA; Gallagher WM
Expert Opin Med Diagn; 2008 Sep; 2(9):1091-4. PubMed ID: 23495928
[TBL] [Abstract][Full Text] [Related]
15. Highlights of the 13th Annual Meeting of the European Council for Cardiovascular Research. 13th Annual Meeting of the European Council for Cardiovascular Research (ECCR). Nice, France, 10-12 October, 2008.
Bader M
Future Cardiol; 2009 Jan; 5(1):23-5. PubMed ID: 19371200
[TBL] [Abstract][Full Text] [Related]
16. Recent trends in computer-aided drug discovery.
Tropsha A
Curr Opin Drug Discov Devel; 2000 May; 3(3):310-3. PubMed ID: 19649864
[TBL] [Abstract][Full Text] [Related]
17. Virtual compound screening in drug discovery.
Stumpfe D; Ripphausen P; Bajorath J
Future Med Chem; 2012 Apr; 4(5):593-602. PubMed ID: 22458679
[TBL] [Abstract][Full Text] [Related]
18. Highlights from the 2013 WIN Symposium: personalised cancer therapy from innovation to implementation.
Schilsky RL
Ecancermedicalscience; 2013; 7():344. PubMed ID: 24009643
[TBL] [Abstract][Full Text] [Related]
19. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
Meanwell NA
Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
[TBL] [Abstract][Full Text] [Related]
20. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States.
Stepan AF; Walker DP; Bauman J; Price DA; Baillie TA; Kalgutkar AS; Aleo MD
Chem Res Toxicol; 2011 Sep; 24(9):1345-410. PubMed ID: 21702456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
